News
The upcoming book, The Art and Science of Palliative Medicine, edited by Howard S. Smith and Julie G. Pilitsis
Annals of Palliative Medicine
2013;
2
(4)
:158-160
.
(15 October 2013)
Editorial
The PARAMOUNT trial in NSCLC: is the amount of benefit clinically meaningful?
Annals of Palliative Medicine
2013;
2
(4)
:161-163
.
(15 October 2013)
Expectations as outcome of effectiveness for patients with metastatic lung cancer
Annals of Palliative Medicine
2013;
2
(4)
:164-166
.
(15 October 2013)
End of life care in lung cancer patients: not at life’s end?
Annals of Palliative Medicine
2013;
2
(4)
:167-169
.
(15 October 2013)
How many drugs in the maintenance setting for non-small-cell lung cancer? For what benefit?
Annals of Palliative Medicine
2013;
2
(4)
:170-172
.
(15 October 2013)
Original Article
The use of opioids at the end-of-life and the survival of Egyptian palliative care patients with advanced cancer
Annals of Palliative Medicine
2013;
2
(4)
:173-177
.
(15 October 2013)
Review Article
Palliative care for patients with locally advanced and metastatic non-small cell lung cancer
Annals of Palliative Medicine
2013;
2
(4)
:178-188
.
(15 October 2013)
Opioid combination: rationale and possible clinical applications
Annals of Palliative Medicine
2013;
2
(4)
:189-196
.
(15 October 2013)
Bridging the communication gap between oncologists and patients receiving palliative therapies
Annals of Palliative Medicine
2013;
2
(4)
:197-201
.
(15 October 2013)
Commentary
Commentary on Alsirafy et al. The use of opioids at the end-of-life and the survival of Egyptian palliative care patients with advanced cancer
Annals of Palliative Medicine
2013;
2
(4)
:202
.
(15 October 2013)
